Deal D L, Chandrasurin P, Shockcor J, Minick D J, Findlay J W, McNulty M J
Wellcome Research Laboratories, Burroughs Wellcome Co., Research Triangle Park, NC 27709.
Drug Metab Dispos. 1992 Nov-Dec;20(6):920-7.
The disposition of the antihistamine, triprolidine, was studied in male and female CD-1 mice after a single oral 50 mg/kg dose of [14C]triprolidine HCl. Urine and feces collected over 72 hr postdosing were analyzed for total radiocarbon, and for parent drug and metabolites by radiochromatography. Structures of metabolites were determined by GC/MS, direct probe MS, FAB/MS, LC/MS, NMR, and IR techniques. More than 80% of the dose was recovered in the urine, with the remainder recovered in the feces. The carboxylic acid analog of triprolidine (219C69) was found to be the major metabolite in urine and feces, accounting for an average of 57.6% of the administered dose. Three minor metabolites were identified as a gamma-aminobutyric acid analog of triprolidine, a pyrrolidinone analog of 219C69, and a pyridine-ring hydroxylated derivative of triprolidine. Parent drug could only be detected in urine and accounted for 0.3% (females) to 1.1% (males) of the dose. The results of this study showed that triprolidine was absorbed well but extensively metabolized when administered orally to mice.
在给雄性和雌性CD-1小鼠单次口服50mg/kg剂量的[14C]盐酸曲普利啶后,对该抗组胺药曲普利啶的处置情况进行了研究。给药后72小时内收集的尿液和粪便进行了总放射性碳分析,并通过放射色谱法分析了母体药物和代谢物。代谢物的结构通过气相色谱/质谱联用(GC/MS)、直接探头质谱(direct probe MS)、快原子轰击质谱(FAB/MS)、液相色谱/质谱联用(LC/MS)、核磁共振(NMR)和红外光谱(IR)技术确定。超过80%的剂量在尿液中回收,其余在粪便中回收。发现曲普利啶的羧酸类似物(219C69)是尿液和粪便中的主要代谢物,平均占给药剂量的57.6%。三种次要代谢物被鉴定为曲普利啶的γ-氨基丁酸类似物、219C69的吡咯烷酮类似物和曲普利啶的吡啶环羟基化衍生物。母体药物仅在尿液中检测到,占剂量的0.3%(雌性)至1.1%(雄性)。本研究结果表明,曲普利啶口服给药后吸收良好,但代谢广泛。